You really cannot make this stuff up

Discussion in 'Shire' started by anonymous, Jul 5, 2017 at 9:48 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Please, for the love of God, stop pretending to be a hard core salesperson because your in pharma. Your not!!!

    I'm a pharma sales rep and yes, maybe back in the day, but now, please.

    It was a great gig, but now, it is not. You may think your at the top, and without warning, you will be cut.

    I'm working on plan b outside of pharma, forget because being a slave to Perry or KK.
     

  2. anonymous

    anonymous Guest


    A.W. is that you?
     
  3. anonymous

    anonymous Guest

    I never said you DID care about OBU or Xiidra. We know that most of you don't and we don't blame you for it. NBU should've never been asked to do that. And for the record, the OBU people that were axed were let go because of performance and metrics. So yes, if you're not selling and moving the needle after 1 year, you might want to start looking for another opportunity. Snowflakes need not apply to sales positions.

    As to my comment about Xiidra being the most successful launch in ophthalmic history, that wasn't SHIRE saying that. That came from one of the optometric journals a few months back. You say "don't trust this company" and complaining about leadership and how they're inept, yet you blindly trust them when that same NBU leadership (the same people that don't give a damn about Xiidra) tells you at a NBU meeting that the Xiidra launch has been a failure. Way to contradict yourself. "Don't listen to management. They're inept."........"Our management says Xiidra launch is a failure." Hmm.

    If you have actually been making calls with ECPs (the actual person that matters in this equation), they'll tell you they love it and offering the 1st 30 days free when it works for many in as little as 2 weeks is the best launch strategy any company has ever done. "Brilliant" is the word that I've heard since August '16. The only negative I hear these days is the prior auths and no Med D coverage. Kind of expected though, so you get it where you can get it.

    I'm not taking up for leadership, they botched quotas and the national goal for 2017 so if your leadership wants to say that Xiidra is failing because it's not hitting goal, whatever. How long have NBU reps not made quotas on Vyvanse because of unrealistic quotas? 2 years? Yet you won't hear anyone at OBU saying Vyvanse has been a failure the last 2 years.

    It's not Xiidra's fault that we're not close to the national goal, nor is it 90% of the OBU reps' fault. The only failure for Xiidra in 2017 was the prediction that the market would grow another 12% which was factored into the IC plan. That hasn't happened. Market is still flat. Med D coverage will eventually get here and the growth will happen again.

    But good luck with that mydayis launch.
     
  4. anonymous

    anonymous Guest

    This is the most communication from TP since he joined Shire.

    Bravo TP!

    Your insight and analysis is remarkable. Not.

    Hope your having a good summer.

    The OBU
     
  5. anonymous

    anonymous Guest

    What we can or cannot do, what we consider possible or impossible, is rarely a function of our true capability. It is more likely a function of our beliefs about who we are. Believe in OBU because we are doing a GREAT job!! A positive future is foreseen!
     
  6. anonymous

    anonymous Guest

    Well this thread just went sideways
     
  7. anonymous

    anonymous Guest

    probably TP trying to get the thread pulled bc someone called him out
     
  8. anonymous

    anonymous Guest

    Who is TP?

    I've heard rumors he is an OBU leader somewhere?

    Is the OBU being led by anyone?
     
  9. anonymous

    anonymous Guest

    You clearly didn't finished reading before you decided to go on a tirade. The post said mydayis will ALSO be a failure due to inept management. So never trust this company.

    No one over here blindly trusts the NBU management . They're the biggest joke in pharma and we dont get paid anymore . Most of us are trying to get out and so should everyone else, including you. But calm down a little before jumping to conclusions.

    The NBU doesn't fault your sales force for failure . We know all about unrealistic goals and expectations and have been experiencing them long before the xiidra launch

    This place is a dumpster fire
     
  10. anonymous

    anonymous Guest

    NBU Sales is a JOKE. All you do is work the sample closet! Last time you detailed a doc?!?!?
     
  11. anonymous

    anonymous Guest

    The NBU doesn't sample unlike the OBU. We have zero ability to get signatures : Clearly this must be a typeo
     
  12. anonymous

    anonymous Guest

    Then what the heck do you really do on a "sales call"? NBU is such a joke!!
     
  13. anonymous

    anonymous Guest

    not a typo. its some bored troll that keeps showing up on all the shire threads lately. clearly, said troll doesnt work for the company as he/she just blows smoke (full of incorrect info too).
     
  14. anonymous

    anonymous Guest

    To be quite frank - - - nothing. Most docs don't even allow us to see them. Reporting is all smoke and mirrors. Easy money and most of the reps work half days at best. NOT GOOD
     
  15. anonymous

    anonymous Guest

    Troll alert
     
  16. anonymous

    anonymous Guest

    Just out of curiosity, who exactly named Xiidra the best launched drug in ophthalmic history?
     
  17. anonymous

    anonymous Guest

    My question exactly. No doubt it was Shire. Another stupid statement from our leaders.
    Next one will be were the best managed company in pharma.
     
  18. anonymous

    anonymous Guest

    What is Vyvanase?
     
  19. anonymous

    anonymous Guest

    NOT GOOD BUT IT IS THE UGLY TRUTH - - - MARKET SHARE HAS BEEN STAGNANT FOT PAST TWO YEARS - - - TIME TO FIRE!
     
  20. anonymous

    anonymous Guest

    Amen